Novartis.com | Contact Us | Help | Site Map | Large Text Version Regular Text Version

Home

LATEST NEWS FROM NOVARTIS ONCOLOGY

07-May-2012

Novartis drug pasireotide LAR shows superior efficacy compared to Sandostatin® LAR® in Phase III trial of patients with acromegaly

26-Apr-2012

Novartis drug Afinitor® approved by FDA as first medication to treat patients with non-cancerous kidney tumors associated with TSC

25-Apr-2012

Novartis drug Signifor® approved in the EU as the first medication to treat patients with Cushing's disease


View Videos of Novartis Patient Stories

LaDonna Lopossa	Carol Lundin	Suzan M.	John Ivey

SEARCH OUR WEBSITES

ABOUT NOVARTIS ONCOLOGY

Learn More About Novartis Oncology

We deliver a broad range of innovative therapies, cancer resources and oncology drugs to improve and extend the lives of cancer patients.

Learn more about Novartis Oncology

Use of this website is governed by our Terms of Use and Privacy Policy. © Novartis AG

Disclaimer: This site is intended to provide information to audiences outside the United States. Please note that not all products listed within this site may be available in all countries. Also, prescribing information and indications for products may differ from country to country, so please consult your local Novartis company for local prescribing and any other information you may be interested in.